During the past decade, Oregon Center For Clinical Investigations Inc conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 42 clinical trials were completed, i.e. on average, 110.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 25 clinical trials were completed. i.e. 312.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Center For Clinical Investigations Inc" #1 sponsor was "Shire" with 15 trials, followed by "Sunovion" with 9 trials sponsored, "Cephalon" with 7 trials sponsored, "Allergan" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Center For Clinical Investigations Inc" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Purdue Pharma LP" with 1 trials as a collaborator and "Purdue Pharma, Canada" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Center For Clinical Investigations Inc" are "ADHD" (9 trials), "Major Depressive Disorder" (8 trials), "Binge Eating Disorder" (6 trials), "Migraine, With or Without Aura" (6 trials) and "Attention Deficit Hyperactivity Disorder" (5 trials). Many other conditions were trialed in "Oregon Center For Clinical Investigations Inc" in a lesser frequency.

Most popular intervention types in "Oregon Center For Clinical Investigations Inc" are "Drug" (77 trials), "Other" (7 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Dasotraline" (4 trials), "Lisdexamfetamine dimesylate" (4 trials), "Rimegepant" (4 trials) and "Atogepant" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Center For Clinical Investigations Inc" are 76 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Oregon Center For Clinical Investigations Inc". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Oregon Center For Clinical Investigations Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Center For Clinical Investigations Inc, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".